Waking action of ursodeoxycholic acid (UDCA) involves histamine and GABAA receptor block.
Since ancient times ursodeoxycholic acid (UDCA), a constituent of bile, is used against gallstone formation and cholestasis. A neuroprotective action of UDCA was demonstrated recently in models of Alzheimer's disease and retinal degeneration. The mechanisms of UDCA action in the nervous system...
Main Authors: | Yevgenij Yanovsky, Stephan R Schubring, Quiaoling Yao, Yan Zhao, Sha Li, Andrea May, Helmut L Haas, Jian-Sheng Lin, Olga A Sergeeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3412845?pdf=render |
Similar Items
-
Polynosological effects of ursodeoxycholic acid (UDCA). Practice of using
by: V. M. Makhov, et al.
Published: (2016-12-01) -
Latest development in the synthesis of ursodeoxycholic acid (UDCA): a critical review
by: Fabio Tonin, et al.
Published: (2018-02-01) -
Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting RAGE Signaling in Diabetic Atherosclerosis.
by: Jihwa Chung, et al.
Published: (2016-01-01) -
Effect of Ursodeoxycholic acid (UDCA) on CYP3A Drug Metabolism: Study with Midazolam in Rats
by: Chein-Chen Huang, et al.
Published: (2003) -
Vitamin E + Ursodeoxycholic Acid (UDCA) Versus Vitamin E for the Treatment of Non-Alcoholic Steatohepatitis (NASH)
by: Sayyed Moayyed Alavian, et al.
Published: (2010-11-01)